We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for ataluren (PTC Therapeutics Australia Pty Ltd)
Active ingredients
ataluren
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
granules for oral suspension
Indication
For the treatment of patients with Duchenne muscular dystrophy
Therapeutic area
Musculoskeletal